2/20
03:23 pm
frln
Form SC 13E3/A Freeline Therapeutics Filed by: Freeline Therapeutics Holdings plc
Neutral
Report
Form SC 13E3/A Freeline Therapeutics Filed by: Freeline Therapeutics Holdings plc
2/20
12:04 pm
frln
Form 25-NSE Freeline Therapeutics Filed by: Nasdaq Stock Market LLC
Neutral
Report
Form 25-NSE Freeline Therapeutics Filed by: Nasdaq Stock Market LLC
2/20
07:14 am
frln
Form 6-K Freeline Therapeutics For: Feb 20
Neutral
Report
Form 6-K Freeline Therapeutics For: Feb 20
2/14
12:16 pm
frln
Form SC 13G/A Freeline Therapeutics Filed by: EVENTIDE ASSET MANAGEMENT, LLC
Low
Report
Form SC 13G/A Freeline Therapeutics Filed by: EVENTIDE ASSET MANAGEMENT, LLC
2/12
04:24 pm
frln
Form SC 13G/A Freeline Therapeutics Filed by: INTEGRATED CORE STRATEGIES (US) LLC
Low
Report
Form SC 13G/A Freeline Therapeutics Filed by: INTEGRATED CORE STRATEGIES (US) LLC
2/12
04:02 pm
frln
Form 6-K Freeline Therapeutics For: Feb 12
Low
Report
Form 6-K Freeline Therapeutics For: Feb 12
1/31
04:11 pm
frln
Form SC 13G/A Freeline Therapeutics Filed by: Tetragon Financial Management LP
Low
Report
Form SC 13G/A Freeline Therapeutics Filed by: Tetragon Financial Management LP